Teva-Erlotinib

  • Generic name

    erlotinib hydrochloride

  • Brand reference

    Tarceva®

  • Strength

    25 mg

  • DIN

    02377691

  • Therapeutic class

    Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor / Protein Kinase Inhibitor (L01XE03)

  • Therapeutic area

    Oncology


  • Package size

    Blister 30

  • Product code

    71971-0127

  • UPC

    068510073273

  • Generic name:

    erlotinib hydrochloride

  • Brand reference:

    Tarceva®

  • Product code:

    71971-0127

  • Strength

    25 mg

  • DIN

    02377691

  • UPC:

    068510073273

  • Therapeutic class

    Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor / Protein Kinase Inhibitor (L01XE03)

  • Therapeutic area:

    Oncology

  • Package size:

    Blister 30

Composition

Active ingredient

erlotinib hydrochloride


Non-medicinal ingredients

colloidal silicon dioxide, hydroxypropyl methylcellulose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, sodium lauryl sulphate, sodium starch glycolate, titanium dioxide and triacetin.

Product characteristics

  • Dosage form

    tablet

  • Shape

    round

  • Marking 1

    93

  • Marking 2

    E2

  • Colour

    white to off-white

  • Secondary colour

  • Scored

  • Flavour

  • Gluten

    no

  • Latex

    not applicable

Disclaimers

All information about raw materials and / or allergen information for Teva Canada’s products is obtained from our suppliers and/or third party affiliates and is based on their records.

Please be advised that the Medical Information department is not always notified of change in third party affiliates and / or change in suppliers of the excipients that may occur over time, and all information provided herein is based on our last current records.

"Latex" – refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process, however this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and / or packaging facilities may be wearing latex gloves

Product monograph/consumer information leaflet


View monograph

Notice

We are modifying our product names to align with our corporate name change. Accordingly, please expect product monographs to contain the “Novo-”, “ratio-”, “ACT”, "CO" prefix or the new “Teva” prefix. These prefixes may be used interchangeably on the website.

Should you have any questions about our product names or our corporate name change, please do not hesitate to contact us. Our Customer Care department can be reached at 1-800-268-4127 regarding your inquiry.